All insiders/SEC Form 4 history
8 Form 4 transactions across 1 company, 2026-04-13 → 2026-04-15.
Total disclosed
$2.79M
Buys
$666K
Sells
$2.13M
Win rate · live
—
Holdings
Marked using
shares-after from the latest filing × live quoteCompany
Trades
Holding value
Last trade
Avg buy / sell
% since last
TVTX
Travere Therapeutics, Inc.
Chief Legal Officer and GC
8
—
105.2K sh
SELL
2026-04-15
$17.97
$41.43
—
Insider trade history
8 disclosed transactions
| Date | Ticker | Code | Shares | Price | Value | Now | % since |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | TVTX | S↓ | 1.6K | $42.53 | $66K | — | — |
| 2026-04-15 | TVTX | S↓ | 5.2K | $41.62 | $218K | — | — |
| 2026-04-14 | TVTX | M↑ | 20.0K | $17.96 | $359K | — | — |
| 2026-04-14 | TVTX | M↑ | 7.5K | $15.46 | $116K | — | — |
| 2026-04-14 | TVTX | S↓ | 7.2K | $41.93 | $303K | — | — |
| 2026-04-14 | TVTX | S↓ | 37.5K | $41.07 | $1.54M | — | — |
| 2026-04-14 | TVTX | M↑ | 10.0K | $19.08 | $191K | — | — |
| 2026-04-13 | TVTX | A↑ | 14.0K | $0.00 | $0 | — | — |
Form 4 codes: P open-market buy · S open-market sell · A grant/award · M option exercise · F tax withholding · G gift. % since is the move from the trade-day reported price to the live quote.